Dipeptidyl peptidase inhibitors

US7550590B2 · kind B2 · utility

Assignee

• Takeda Pharmaceutical Company Limited · JP

Inventors

• Jun Feng · San Diego, US
• Stephen L. Gwaltney · San Diego, US
• Stephen W. Kaldor · Indianapolis, US
• Jeffrey Alan Stafford · San Diego, US
• Michael B. Wallace · San Diego, US
• Zhiyuan Zhang · Beijing, CN

Key dates

• Filing date: Mar 24, 2004
• Grant date: Jun 23, 2009
• Expiry date: Mar 24, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds, pharmaceuticals, kits, and methods are provided for use with DPP-IV and other S9 protease that comprise a compound comprising the formula:wherein Q is selected from the group of CO, SO, SO2, or C═NR9; and R1, R2, R3 and R4 are as defined herein.